Literature DB >> 12716386

Langerhans cell histiocytosis: an evaluation of histopathological parameters, demonstration of proliferation by Ki-67 and mitotic bodies.

Micha I Bank1, Pia Rengtved, Henrik Carstensen, Bodil L Petersen.   

Abstract

PURPOSE: Langerhans cell histiocytosis (LCH) is a disease with a variable clinical manifestation, being localised (SS) or disseminated (MS). The etiology and pathogenesis of LCH is unknown. It is a proliferative disorder of monoclonal origin, but not necessarily neoplastic. In our study we evaluated histopathological parameters and proliferative activity in LCH.
MATERIALS AND METHODS: Infiltrates from 43 patients with LCH were investigated (nSS=32, nMS=11). We evaluated different histopathological parameters semiquantitatively, demonstrating proliferation using immunohistochemistry for Ki-67.
RESULTS: Overall, the histopathological picture of LCH was heterogeneous. The degree of eosinophilia and presence of necroses was significantly higher in SS-infiltrates compared to MS-infiltrates. Mitotic figures were detected in more than half the infiltrates. The Langerhans origin was verified by CD1a. Ki-67 was highly expressed in all but one infiltrate.
CONCLUSIONS: The presence of necrosis and the degree of eosinophilia are related to SS-disease in our study. Ki-67 expression and the presence of mitotic figures indicate that local proliferation contributes to the accumulation of Langerhans cells. Supported by the histopathological appearance of the lesions and a level of Ki-67 expression lower than that of neoplastic tissue, we suggest that LCH is a reactive condition, possibly induced by immunostimulation caused by unknown agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716386     DOI: 10.1034/j.1600-0463.2003.1110202.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  6 in total

Review 1.  Langerhans-Cell Histiocytosis.

Authors:  Carl E Allen; Miriam Merad; Kenneth L McClain
Journal:  N Engl J Med       Date:  2018-08-30       Impact factor: 91.245

2.  Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry.

Authors:  Ichiro Murakami; Takashi Oka; Satoshi Kuwamoto; Masako Kato; Kazuhiko Hayashi; Jean Gogusev; Toshihiko Imamura; Akira Morimoto; Shinsaku Imashuku; Tadashi Yoshino
Journal:  Virchows Arch       Date:  2011-05-22       Impact factor: 4.064

3.  Clinicopathological and Immunohistochemical Study of Head and Neck Langerhans Cell Histiocytosis from Latin America.

Authors:  Natália Rocha Bedran; Román Carlos; Bruno Augusto Benevenuto de Andrade; Ana Paula Silva Bueno; Mário José Romañach; Cristiane Bedran Milito
Journal:  Head Neck Pathol       Date:  2017-11-21

4.  Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis.

Authors:  Cristiana E T da Costa; Nicola E Annels; Claudia M J M Faaij; Ramses G Forsyth; Pancras C W Hogendoorn; R Maarten Egeler
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

5.  Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.

Authors:  Brigitte Senechal; Gaelle Elain; Eric Jeziorski; Virginie Grondin; Natacha Patey-Mariaud de Serre; Francis Jaubert; Kheira Beldjord; Arielle Lellouch; Christophe Glorion; Michel Zerah; Pierre Mary; Mohammed Barkaoui; Jean Francois Emile; Liliane Boccon-Gibod; Patrice Josset; Marianne Debré; Alain Fischer; Jean Donadieu; Frederic Geissmann
Journal:  PLoS Med       Date:  2007-08       Impact factor: 11.069

6.  Eosinophilic granuloma/Langerhans cell histiocytosis: Pediatric neurosurgery update.

Authors:  Sandi Lam; Gaddum D Reddy; Rory Mayer; Yimo Lin; Andrew Jea
Journal:  Surg Neurol Int       Date:  2015-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.